Regulatory T and CXCR3+ Circulating Tfh Cells Concordantly Shape the Neutralizing Antibody Responses in Individuals Who Have Recovered from Mild COVID-19.

Regulatory T and CXCR3+ Circulating Tfh Cells Concordantly Shape the Neutralizing Antibody Responses in Individuals Who Have Recovered from Mild COVID-19.

Publication date: Jul 25, 2024

Regulatory T (Treg) cells are involved in the antiviral immune response in patients with coronavirus disease 2019 (COVID-19); however, whether Treg cells are involved in the neutralizing antibody (nAb) response remains unclear. Here, we found that individuals who recovered from mild but not severe COVID-19 had significantly greater frequencies of Treg cells and lower frequencies of CXCR3+ circulating T follicular helper (cTfh) cells than healthy controls. Furthermore, the frequencies of Treg and CXCR3+ cTfh cells were negatively and positively correlated with the nAb responses, respectively, and Treg cells was inversely associated with CXCR3+ cTfh cells in individuals who recovered from mild COVID-19 but not in those with severe disease. Mechanistically, Treg cells inhibited memory B-cell differentiation and antibody production by limiting the activation and proliferation of cTfh cells, especially CXCR3+ cTfh cells, and functional molecule expression. This study provides novel insight showing that mild COVID-19 elicits concerted nAb responses, which are shaped by both Treg and Tfh cells.

Concepts Keywords
Antibody Adult
Antiviral Aged
Concerted Antibodies, Neutralizing
Coronavirus Antibodies, Neutralizing
Mild Antibodies, Viral
Antibodies, Viral
COVID-19
COVID-19
CXCR3 protein, human
Female
Humans
Male
Memory B Cells
Middle Aged
neutralizing antibody
Receptors, CXCR3
Receptors, CXCR3
regulatory T cell
T-Lymphocytes, Regulatory

Semantics

Type Source Name
disease MESH COVID-19
disease IDO immune response
disease MESH Long Covid
disease IDO cell

Original Article

(Visited 3 times, 1 visits today)